Reports for TEVA-BUPRENORPHINE/NALOXONE

Brand name

TEVA-BUPRENORPHINE/NALOXONE

Company Name
TEVA CANADA LIMITED
Drug Identification Number
02453916
Ingredients
BUPRENORPHINE
NALOXONE
Ingredient Strength
8 MG
2 MG
ATC Code
N07BC
N07BC
ATC Descriptor
DRUGS USED IN ADDICTIVE DISORDERS
DRUGS USED IN ADDICTIVE DISORDERS
Status
MARKETED
Shortage reports
Brand name Packaging Size Status Date Created Date Updated Reports
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2019-09-26 2020-01-24 94896
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2024-03-07 2024-06-27 221537
TEVA-BUPRENORPHINE/NALOXONE 30 Actual shortage 2025-08-29 2025-10-30 266199

Showing 1 to 4 of 4

Discontinuation reports
Brand name Packaging Size Status Date Created Date Updated Reports

Showing 1 to 0 of 0